Annual Meeting of the Japanese Society of Toxicology
The 45th Annual Meeting of the Japanese Society of Toxicology
Displaying 201-250 of 466 articles from this issue
Oral Session
  • Cai ZONG, Rieka HASEGAWA, Makoto URUSHITANI, Toshihiro SAKURAI, Seiich ...
    Session ID: O-39
    Published: 2018
    Released on J-STAGE: August 10, 2018
    CONFERENCE PROCEEDINGS FREE ACCESS

    Objectives: Acrylamide (ACR), an environmental soft electrophile, is used for synthesis of polyacrylamide in industry and for production of gels in scientific research. Recently ACR contamination has also been reported in certain carbohydrate-rich foods cooked at high temperature. Neurotoxicity of ACR has been reported in humans and experimental animals. However, underlying mechanism of ACR neurotoxicity remains elusive. The present study aims to investigate the role of microglial activation and neuroinflammation in the neurotoxicity of ACR. Methods: In vivo: Male 10-week-old Wistar rats were exposed to ACR by gavage at 0, 0.2, 2, or 20 mg/kg BW, once/day, 7 days/week, for 5 weeks. Expression levels of inflammation related genes and microglial markers in the cerebral cortex were examined by quantitative real-time PCR. In vitro: Murine immortalized microglial BV-2 cells were treated with ACR at different dose (0, 5, 50, or 500 μM), for different time (0, 4, 6, 8, 12, 18, 24, or 36 h). MTS assay was performed to evaluate effects of ACR exposure on cell viability. Expression of inflammation related genes was examined by quantitative real-time PCR. Results: In vivo studies showed that ACR exposure at 20 mg/kg BW for 5 weeks significantly increased expression of pro-inflammatory cytokines IL-1β and IL-6 in rat cerebral cortex. ACR exposure at 2 mg/kg BW for 5 weeks significantly increased IL-18 expression level in the cerebral cortex. ACR exposure at 2 mg/kg BW for 5 weeks significantly increased expression of microglial markers, including CD11b and CD40, in rat cerebral cortex. For in vitro study, MTS assay showed that ACR exposure ranging from 10 to 1000 μM did not decrease BV2 microglia cell viability; while ACR exposure at more than 2000 μM significantly decreased BV2 cell viability. ACR exposure increased expression of pro-inflammatory cytokines IL-1β and IL-18 in BV2 microglia, in a time- and dose- dependent manner. Expression of iNOS, which is also an inflammatory marker, was increased after ACR exposure. Moreover, NLRP3 inflammasome-related genes, including NLRP3, Caspase 1 and ASC, which regulate production of cytokines IL-1β and IL 18, were also increased in the cerebral cortex of rats exposed to ACR at 2 mg/kg BW for 5-weeks. Conclusions: The above in vivo and in vitro results suggest that microglia activation and neuroinflammation play roles in neurotoxicity of ACR, probably through NLRP3 inflammasome pathway.

    Download PDF (680K)
  • Kentaro ANDO, Atsuhiko T NAITO, Ai GOTO, Yuji NAKAMURA, Mihoko HAGIWAR ...
    Session ID: O-40
    Published: 2018
    Released on J-STAGE: August 10, 2018
    CONFERENCE PROCEEDINGS FREE ACCESS
Excellent Presentation Award (Poster)
feedback
Top